Ownership history in Ghost Tree Capital, LLC · 14 quarters on record
This page tracks every 13F SEC filing in which Ghost Tree Capital, LLC reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | ADDED | 350,000 | +115,000 | +48.9% | 3.48% | $11.5M | $32.89 |
| 2024 Q2 | REDUCED | 235,000 | -65,000 | -21.7% | 2.00% | $6.4M | $27.18 |
| 2024 Q1 | UNCHANGED | 300,000 | — | 0% | 3.02% | $10.9M | $36.35 |
| 2023 Q4 | REDUCED | 300,000 | -100,000 | -25.0% | 1.99% | $6.1M | $20.25 |
| 2023 Q3 | ADDED | 400,000 | +250,000 | +166.7% | 2.34% | $7.1M | $17.77 |
| 2023 Q2 | ADDED | 150,000 | +70,000 | +87.5% | 0.89% | $2.7M | $18.07 |
| 2023 Q1 | UNCHANGED | 80,000 | — | 0% | 0.30% | $1.0M | $12.57 |
| 2022 Q4 | REDUCED | 80,000 | -40,000 | -33.3% | 0.50% | $1.2M | $14.66 |
| 2022 Q3 | UNCHANGED | 120,000 | — | 0% | 0.58% | $2.1M | $17.12 |
| 2022 Q2 | UNCHANGED | 120,000 | — | 0% | 0.91% | $1.8M | $14.60 |
As of 2025 Q4 — sorted by position size